Dojindo Home
Search Products
Entire Site
Product Info Ordering Info Catalog Request Newsletter Company Profile Contact Us Home
Home>>Newsletter

Liposomal Vaccine Containing DDPC


Drug delivery system (DDS) has been studied by a great number of researchers over several decades. A DDS using liposome is thought to be one of the most sophysticated methods.
Professor Junzo Sunamoto (the Department of Polymer Chemistry, Kyoto University) and his co-workeres showed the possibility of liposomal vaccine system using an artificial boundary lipid.[1] In this paper, it is reported that they prepared a liposome containing an artificial boundary lipid, 1,2- dimyristoylamido-1,2-deoxyphosphatidylcholine (DDPC) for direct transfer of membrane protein of BALB RVD leukemia cells. The liposome constructed with 20 mol% of dimyristoylphosphatidylcholine (DMPC) and 80 mol% of DDPC showed higher membrane protein-transfer efficiency than any other liposomes. Membrane proteins could transfer from BALB RVD leukemia cells to this liposome with an incubation at 37C for 1 hr.
This membrane protein-transferred liposome showed significantly higher efficiency of macrophage uptake compared with other liposomes, such as no membrane protein-transferred liposome and the liposome contained proteins extracted with butanol. This results supported that tumor surface antigenic proteins (TSAPs) were involved in membrane proteins.
They also tested this liposome in vivo.[2] Cytotoxic T lymphocytes (CTLs) of immunized CB6F1 mice with TSAP-transferred liposome were largely produced by an intradermal injection of BALB RVD leukemia cells, and the tumor growth was effectively prevented as they expected.
Further information of the liposomal vaccine would be available from their recent report.[3]

DDPC is only available from Dojindo Laboratories.




References
  1. J. Sunamoto, T. Noguchi, T. Sato, K. Akiyoshi, R. Shibata, E. Nakayama and H. Shiku, "Direct transfer of tumor surface antigenic protein (TSAP) from tumor cell to liposome for making liposomal vaccine", J. Control. Release, 20, 143-154 (1992).
  2. R. Shibata, T. Noguchi, T. Sato, K. Akiyoshi, J. Sunamoto, H. Shiku, and E. Nakayama, "Induction of in vitro and in vivo antitumor response by sensitization of mice with liposomes reconstituted crude butanol extract from leukemia cells and transferred intermembranously with cell surface proteins", Int. J. Cancer, 48, 434-442 (1991).
  3. K. Suzuki, Y. Okumura, T. Sato, A. Oki, M. Oki, and J. Sunamoto, "Direct transfer of blood group antigens from human erythrocytes to liposomes", Transfus., (1995) in press.